ENDRA Life Sciences Inc.
Index- P/E- EPS (ttm)-0.28 Insider Own0.90% Shs Outstand43.05M Perf Week1.16%
Market Cap20.50M Forward P/E- EPS next Y-0.13 Insider Trans38.80% Shs Float- Perf Month38.30%
Income-11.80M PEG- EPS next Q-0.06 Inst Own6.90% Short Float- Perf Quarter68.58%
Sales- P/S- EPS this Y56.10% Inst Trans9.02% Short Ratio0.89 Perf Half Y-15.46%
Book/sh0.21 P/B1.58 EPS next Y35.00% ROA-83.90% Target Price5.00 Perf Year-77.53%
Cash/sh0.12 P/C2.89 EPS next 5Y- ROE-98.50% 52W Range0.18 - 2.09 Perf YTD-51.92%
Dividend- P/FCF- EPS past 5Y18.30% ROI- 52W High-84.09% Beta1.37
Dividend %- Quick Ratio6.00 Sales past 5Y- Gross Margin- 52W Low84.78% ATR0.03
Employees22 Current Ratio7.50 Sales Q/Q- Oper. Margin- RSI (14)57.86 Volatility8.08% 9.57%
OptionableNo Debt/Eq0.00 EPS Q/Q-4.90% Profit Margin- Rel Volume0.68 Prev Close0.36
ShortableYes LT Debt/Eq0.00 EarningsAug 15 AMC Payout- Avg Volume728.14K Price0.33
Recom2.00 SMA2010.50% SMA5025.54% SMA200-35.30% Volume498,390 Change-7.87%
Aug-15-22 04:05PM  
Aug-08-22 10:16AM  
Aug-04-22 08:00AM  
Aug-02-22 08:00AM  
Aug-01-22 08:00AM  
Jul-11-22 08:00AM  
Jun-28-22 08:00AM  
Jun-08-22 08:00AM  
May-25-22 08:00AM  
May-16-22 08:00AM  
May-12-22 04:05PM  
May-10-22 08:00AM  
May-02-22 08:00AM  
Apr-21-22 08:00AM  
Mar-31-22 08:00AM  
Mar-30-22 04:05PM  
Mar-22-22 08:00AM  
Mar-09-22 08:00AM  
Mar-08-22 08:00AM  
Feb-15-22 08:55AM  
Feb-11-22 08:00AM  
Feb-10-22 07:10AM  
Feb-09-22 04:05PM  
Jan-24-22 08:15AM  
Jan-05-22 07:00AM  
Dec-30-21 07:57AM  
Dec-13-21 08:00AM  
Nov-29-21 08:00AM  
Nov-16-21 09:15AM  
Nov-15-21 06:15PM  
Nov-08-21 08:00AM  
Oct-13-21 08:00AM  
Oct-05-21 08:00AM  
Sep-07-21 08:00AM  
Aug-12-21 04:05PM  
Aug-02-21 08:00AM  
Jul-20-21 08:00AM  
Jul-07-21 08:00AM  
Jun-25-21 05:18AM  
Jun-15-21 08:35AM  
Jun-09-21 08:00AM  
May-17-21 04:05PM  
May-06-21 08:00AM  
May-04-21 08:30AM  
Apr-19-21 10:18AM  
Apr-08-21 08:30AM  
Mar-25-21 04:05PM  
Mar-19-21 07:46AM  
Mar-18-21 08:00AM  
Mar-17-21 04:05PM  
Mar-02-21 08:00AM  
Feb-17-21 08:00AM  
Jan-26-21 08:00AM  
Jan-13-21 09:00AM  
Jan-08-21 09:00AM  
Dec-23-20 09:00AM  
Dec-21-20 09:00AM  
Dec-18-20 12:30PM  
Dec-15-20 11:35PM  
Dec-07-20 09:00AM  
Dec-03-20 09:20AM  
Nov-16-20 04:01PM  
Nov-12-20 09:00AM  
Nov-11-20 09:00AM  
Nov-05-20 09:00AM  
Oct-28-20 08:00AM  
Oct-13-20 09:00AM  
Oct-02-20 09:00AM  
Sep-15-20 09:00AM  
Sep-14-20 09:00AM  
Sep-08-20 12:18PM  
Sep-02-20 04:00PM  
Aug-31-20 05:00PM  
Aug-27-20 09:00AM  
Aug-24-20 09:00AM  
Aug-05-20 04:40PM  
Jul-23-20 04:00PM  
Jul-22-20 09:00AM  
Jul-13-20 09:00AM  
Jun-30-20 08:12AM  
Jun-23-20 08:15AM  
Jun-08-20 04:00PM  
Jun-03-20 09:00AM  
May-14-20 04:00PM  
May-06-20 08:00AM  
May-01-20 08:00AM  
Apr-30-20 08:00AM  
Apr-13-20 04:05PM  
Mar-26-20 04:05PM  
Mar-19-20 08:15AM  
Mar-17-20 08:30AM  
Mar-11-20 10:20AM  
Mar-10-20 08:00AM  
Mar-09-20 08:00AM  
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Thornton Michael MilosChief Technology OfficerMay 26Buy0.2125,0005,250332,775May 31 08:46 AM
Thornton Michael MilosChief Technology OfficerMay 18Buy0.2225,0005,500307,775May 23 04:30 PM
Michelon Francois RogerChief Executive OfficerMay 17Buy0.195,10096997,191May 19 07:00 AM
Tokman Alexander YDirectorMay 16Buy0.20100,00019,630132,857May 17 04:14 PM
Basenese LouDirectorAug 26Sale1.855,0009,25049,068Aug 27 04:15 PM
Basenese LouDirectorAug 25Sale1.8345,00082,35054,068Aug 27 04:15 PM